RSV: Clinical Trials

3 trials for RSV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Active not recruiting 1, Not yet recruiting 1, Recruiting 1

Follow RSV: new trials by email Literature Review of RSV trials Research Report on RSV

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RSV Vaccination to Reduce Recurrent AECOPD
RSV vaccination (Arexvy, GlaxoSmithKline) - COPD, RSV
Phase 4Not yet recruitingChinese University of Hong Kong3202027-07-012026-04-13
Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
Tdap Vaccine Administration, RSV Vaccine, Saline (as a placebo) - RSV, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination
Phase 4RecruitingCanadian Immunization Research Network602025-10-162026-10-22
Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults
RSV prefusion F protein-based vaccine - RSV
Phase 4Active not recruitingTor Biering-Sørensen6900002024-11-182026-05-29

Narrower conditions

Diphtheria (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Respiratory Tract Diseases (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Chronic Disease (1)  ·  Corynebacterium Infections (1)  ·  Disease Attributes (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiratory Tract Diseases (1)

Interventions

Boostrix (1)  ·  Respiratory Syncytial Virus Vaccines (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  abrysvo (1)  ·  arexvy (1)  ·  halofantrine (1)

Sponsors

Canadian Immunization Research Network (1)  ·  Chinese University of Hong Kong (1)  ·  Tor Biering-Sørensen (1)

Countries

Canada (1)  ·  Denmark (1)  ·  Hong Kong (1)  ·  Spain (1)

Top investigators

Bahaa Abu-Raya, M.D., PhD (1)

Results publications

PMID 40738309, PMID 40884493, PMID 40888695, PMID 42666088, PMID 42666095, PMID 42702887